Therefore, we believe that some of these drugs could be developed as potential treatments to delay or prevent blindness in rhodopsin retinitis pigmentosa patients.

• 因此，我们认为，这些药物可能发展成为潜在的治疗方法，延误或阻止失明的视紫红质视网膜色素变性病人。